Feature | Â | Observed | Expeceted | SIR | (95% CI) | Ratio of SIRs | (95% CI) | P |
---|---|---|---|---|---|---|---|---|
Number of mitoses >50 | Absent | 60 | 28.50 | 2.11 | (1.64 to 2.71) | 1.91 | (0.83 to 3.87) | 0.07 |
 | Present | 9 | 2.24 | 4.02 | (2.09 to 7.73) |  |  |  |
Nuclear grade - malignant | Absent | 10 | 4.67 | 2.14 | (1.15 to 3.98) | 1.06 | (0.54 to 2.32) | 0.9 |
 | Present | 59 | 26.06 | 2.26 | (1.75 to 2.92) |  |  |  |
Tubule formation <10 | Absent | 16 | 7.86 | 2.04 | (1.25 to 3.32) | 1.14 | (0.64 to 2.13) | 0.7 |
 | Present | 53 | 22.87 | 2.32 | (1.77 to 3.03) |  |  |  |
Syncytial pattern ≥75% | Absent | 64 | 29.42 | 2.18 | (1.70 to 2.78) | 1.75 | (0.55 to 4.31) | 0.2 |
 | Present | 5 | 1.31 | 3.81 | (1.58 to 9.14) |  |  |  |
Circumscribed | Absent | 51 | 26.29 | 1.94 | (1.47 to 2.55) | 2.09 | (1.15 to 3.63) | 0.01 |
 | Present | 18 | 4.45 | 4.04 | (2.55 to 6.42) |  |  |  |
Pushing margins | Absent | 66 | 29.98 | 2.10 | (1.64 to 2.69) | 3.76 | (1.33 to 8.64) | 0.002 |
 | Present | 6 | 0.76 | 7.90 | (3.55 to 17.59) |  |  |  |
Lymphocytic infiltrate I - diffuse | Absent | 38 | 19.42 | 1.96 | (1.42 to 2.69) | 1.40 | (0.84 to 2.31) | 0.2 |
 | Present | 31 | 11.32 | 2.74 | (1.93 to 3.89) |  |  |  |
Lymphocytic infiltrate II-intense | Absent | 53 | 25.89 | 2.05 | (1.56 to 2.68) | 1.61 | (0.86 to 2.86) | 0.1 |
 | Present | 16 | 4.85 | 3.30 | (2.02 to 5.39) |  |  |  |
Glandular growth pattern | Absent | 25 | 7.58 | 3.30 | (2.23 to 4.88) | 0.58 | (0.34 to 0.98) | 0.03 |
 | Present | 44 | 23.16 | 1.90 | (1.41 to 2.55) |  |  |  |
Lobular growth pattern | Absent | 36 | 18.34 | 1.96 | (1.42 to 2.72) | 1.36 | (0.82 to 2.24) | 0.2 |
 | Present | 33 | 12.40 | 2.66 | (1.89 to 3.74) |  |  |  |
Trabecular growth pattern | Absent | 54 | 25.90 | 2.09 | (1.60 to 2.72) | 1.49 | (0.78 to 2.67) | 0.2 |
 | Present | 15 | 4.84 | 3.10 | (1.87 to 5.15) |  |  |  |
Tubular growth pattern | Absent | 59 | 25.25 | 2.34 | (1.81 to 3.02) | 0.78 | (0.36 to 1.54) | 0.5 |
 | Present | 10 | 5.49 | 1.82 | (0.98 to 3.39) |  |  |  |
Acinar growth pattern | Absent | 62 | 26.10 | 2.37 | (1.85 to 3.04) | 0.65 | (0.25 to 1.42) | 0.3 |
 | Present | 7 | 4.56 | 1.54 | (0.73 to 3.22) |  |  |  |
Sclerosis - extensive | Absent | 8 | 1.45 | 5.52 | (2.76 to 11.04) | 0.38 | (0.18 to 0.91) | 0.01 |
 | Present | 61 | 29.29 | 2.08 | (1.62 to 2.68) |  |  |  |
Extensive intraductal carcinoma | Absent | 51 | 25.61 | 1.99 | (1.51 to 2.62) | 1.77 | (0.97 to 3.06) | 0.04 |
 | Present | 18 | 5.12 | 3.51 | (2.21 to 5.58) |  |  |  |
Necrosis | Absent | 48 | 21.35 | 2.25 | (1.70 to 2.98) | 0.99 | (0.57 to 1.69) | 1.0 |
 | Present | 21 | 9.39 | 2.24 | (1.46 to 3.43) |  |  |  |
Apoptosis - moderate or intense | Absent | 12 | 6.64 | 1.81 | (1.03 to 3.18) | 1.31 | (0.69 to 2.68) | 0.4 |
 | Present | 57 | 24.10 | 2.37 | (1.83 to 3.07) |  |  |  |
Lymphatic invasion | Absent | 53 | 21.10 | 2.51 | (1.92 to 3.29) | 0.76 | (0.35 to 1.17) | 0.1 |
 | Present | 16 | 9.64 | 1.66 | (1.02 to 2.71) |  |  |  |
ER positive | Absent | 25 | 10.00 | 2.50 | (1.69 to 3.70) | 0.65 | (0.44 to 1.33) | 0.3 |
 | Present | 34 | 17.85 | 1.91 | (1.36 to 2.67) |  |  |  |
PR positive | Absent | 26 | 9.10 | 2.86 | (1.95 to 4.20) | 0.70 | (0.38 to 1.13) | 0.1 |
 | Present | 35 | 18.78 | 1.86 | (1.34 to 2.60) |  |  |  |